MYCN and acute lymphoblastic leukemia: To assess the efficacy of MYCN inhibition as a potential therapeutic strategy in T-ALL, we examined pediatric T-ALL patient samples isolated from bone marrow or peripheral blood for their sensitivity to PNA-MYCN.